APPLICATION
ANDA205781
TYPE
ANDA
ORIGINAL APPROVAL
2017-07-12
LATEST ACTION
2019-06-27
ROUTE
TOPICAL, TRANSDERMAL
DOSAGE FORM
GEL
MARKETING STATUS
Prescription
Products
TESTOSTERONEPrescription
TESTOSTERONE 1.62% (40.5MG/2.5GM PACKET) · GEL · TRANSDERMAL
TESTOSTERONEPrescription
TESTOSTERONE 1.62% (20.25MG/1.25GM PACKET) · GEL · TRANSDERMAL
Approval history
2019-06-27Labeling · Supplement 4 · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.